In-vitro performance of a single-chambered total artificial heart in a Fontan circulation.

Congenital heart disease Fontan circulation Mock circulation loop (MCL) Single ventricle Total artificial heart (TAH)

Journal

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs
ISSN: 1619-0904
Titre abrégé: J Artif Organs
Pays: Japan
ID NLM: 9815648

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 18 02 2021
accepted: 26 04 2021
pubmed: 7 5 2021
medline: 26 2 2022
entrez: 6 5 2021
Statut: ppublish

Résumé

An in-vitro study was conducted to investigate the general feasibility of using only one pumping chamber of the SynCardia total artificial heart (TAH) as a replacement of the single ventricle palliated by Fontan circulation. A mock circulation loop was used to mimic a Fontan circulation. The combination of both ventricle sizes (50 and 70 cc) and driver (Freedom Driver and Companion C2 Driver) was investigated. Two clinical relevant scenarios (early Fontan; late Fontan) as derived from literature data were set up in the mock loop. The impact of increased transpulmonary pressure gradient, low atrial pressure, and raised central venous pressure on cardiac output was studied. From a hemodynamic point, the single-chambered TAH performed sufficiently in the setting of the Fontan circulation. Increased transpulmonary pressure gradient, from ideal to pulmonary hypertension, decreased the blood flow in combinations by almost 2 L/min. In the early Fontan scenario, a cardiac output of 3-3.5 L/min was achieved using the 50 cc ventricle, driven by the Companion C2 Driver. Even under pulmonary hypertension, cardiac outputs greater than 4 L/min could be obtained with the 70 cc pump chamber in the late Fontan scenario. In the clinically relevant Fontan scenarios, implementation of the single chambered TAH performed successfully from a hemodynamic point of view. The replacement of the failing univentricular heart by a single chamber of the SynCardia TAH may provide an alternative to a complex biventricular repair procedure or ventricular support in Fontan patients.

Identifiants

pubmed: 33956261
doi: 10.1007/s10047-021-01273-5
pii: 10.1007/s10047-021-01273-5
pmc: PMC8866354
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Informations de copyright

© 2021. The Author(s).

Références

ASAIO J. 2015 May-Jun;61(3):274-81
pubmed: 25551416
J Thorac Cardiovasc Surg. 2017 Apr;153(4):912-920
pubmed: 28108065
Expert Rev Med Devices. 2017 Jun;14(6):449-459
pubmed: 28532240
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
Interact Cardiovasc Thorac Surg. 2010 Mar;10(3):428-33
pubmed: 19995891
Artif Organs. 2015 Jul;39(7):550-8
pubmed: 25808201
Circ Cardiovasc Imaging. 2010 Sep;3(5):623-31
pubmed: 20631032
J Thorac Cardiovasc Surg. 2004 Nov;128(5):693-702
pubmed: 15514596
Ann Thorac Surg. 2014 Apr;97(4):1438-40
pubmed: 24694426
Artif Organs. 2017 Jan;41(1):E1-E14
pubmed: 27859378
Can J Cardiol. 2013 Jul;29(7):796-802
pubmed: 23683470
Int J Artif Organs. 2016 Nov 29;39(10):502-508
pubmed: 27768204
Congenit Heart Dis. 2016 Dec;11(6):589-597
pubmed: 26932151
Am Heart J. 2017 Jul;189:9-18
pubmed: 28625386
Circulation. 2006 Jul 25;114(4):273-80
pubmed: 16847155
ASAIO J. 2014 Nov-Dec;60(6):707-15
pubmed: 25158887
Congenit Heart Dis. 2013 May-Jun;8(3):182-6
pubmed: 23510301
Heart. 2016 Jul 15;102(14):1081-6
pubmed: 27220691
Ann Am Thorac Soc. 2016 Feb;13(2):276-84
pubmed: 26848601
Circulation. 2008 Sep 30;118(14 Suppl):S177-81
pubmed: 18824752
Eur J Cardiothorac Surg. 2013 Mar;43(3):e49-57
pubmed: 23396878
Artif Organs. 2016 Jan;40(1):34-42
pubmed: 26526959
Pediatr Int. 2017 Feb;59(2):141-144
pubmed: 27378014
Thorax. 1971 May;26(3):240-8
pubmed: 5089489
J Thorac Cardiovasc Surg. 2006 Jun;131(6):1407-8
pubmed: 16733184
Circulation. 2007 Sep 11;116(11 Suppl):I157-64
pubmed: 17846297
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2015;18(1):17-24
pubmed: 25939838
Int J Artif Organs. 2014 Jan;37(1):71-80
pubmed: 24634320

Auteurs

Stephan Hildebrand (S)

Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074, Aachen, Germany. hildebrand@ame.rwth-aachen.de.

Sascha Groß-Hardt (S)

Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074, Aachen, Germany.

Thomas Schmitz-Rode (T)

Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, Germany.

Ulrich Steinseifer (U)

Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074, Aachen, Germany. steinseifer@ame.rwth-aachen.de.

Sebastian Victor Jansen (SV)

Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH